title: Oxytocin precursor gene expression in bovine skeletal muscle is regulated by 17β-oestradiol and dexamethasone.
abstract: Growth promoter administration, in livestock, potentially poses a major threat to public health, due to the potential endocrine and carcinogenic activity of residues, accumulating in edible tissues, such as skeletal muscle. Therefore, development of new screening tests and methods for the detection of illicit treatments of food animals would be useful. In this study the serum concentrations of oxytocin peptide were measured in beef cattle receiving 17β oestradiol, dexamethasone or placebo over a period of 40 days. Changes in gene expression of oxytocin precursor in skeletal muscle were also examined in these animals. Serum analysis using an oxytocin EIA kit indicated a significant up-regulation of the biosynthesis of this nonapeptide only in cattle after 17β oestradiol, but not after dexamethasone or placebo treatment. Quantitative PCR (qPCR) analysis showed a significant overexpression of the oxytocin precursor gene by 33.5 and 13.3-fold in cattle treated with 17β oestradiol and dexamethasone, respectively, in comparison to placebo treated animals. Regulation of gene expression by some myogenic regulatory factors in skeletal muscle was also evaluated in these animal groups, confirming the activity of both growth promoters on this gene. To investigate the use of the oxytocin precursor gene as biomarker for 17β oestradiol and dexamethasone treatment in beef cattle, an absolute quantification of this gene by qPCR was developed. A standard curve was generated and developed with TaqMan® technology and optimal criterion value, sensitivity and specificity of this screening method were established through ROC analysis. This analysis suggested that the up-regulation of oxytocin precursor gene expression in skeletal muscle tissue is a valid marker for detection of illicit 17β oestradiol and/or dexamethasone use in beef cattle. This method may serve as a novel diagnostic tool in the screening phase, and, if introduced in routine testing, may significantly improve overall efficacy and success of the food screening process ordered by state authorities.
authors.affiliation: Department of Veterinary Science, University of Turin, Grugliasco, Turin, Italy. sara.divari@unito.it
authors.forename: S
authors.initials: S
authors.lastname: Divari
authors.forename: P
authors.initials: P
authors.lastname: Pregel
authors.forename: F T
authors.initials: FT
authors.lastname: Cannizzo
authors.forename: L
authors.initials: L
authors.lastname: Starvaggi Cucuzza
authors.forename: N
authors.initials: N
authors.lastname: Brina
authors.forename: B
authors.initials: B
authors.lastname: Biolatti
mesh_terms: D000818:Animals; D002417:Cattle / Q000097:blood / Q000235:genetics* / Q000378:metabolism; D003907:Dexamethasone / Q000378:metabolism; D004958:Estradiol / Q000378:metabolism*; D015870:Gene Expression; D008460:Meat / Q000032:analysis*; D018482:Muscle, Skeletal / Q000378:metabolism*; D000072340:NIMA-Interacting Peptidylprolyl Isomerase; D010121:Oxytocin / Q000096:biosynthesis* / Q000097:blood; D019696:Peptidylprolyl Isomerase / Q000235:genetics* / Q000378:metabolism; D015854:Up-Regulation
chemical_list: D000072340:NIMA-Interacting Peptidylprolyl Isomerase; D004958:Estradiol; D010121:Oxytocin; D003907:Dexamethasone; D019696:Peptidylprolyl Isomerase
keywords: 17β Oestradiol; Bovine skeletal muscle; Dexamethasone; Oxytocin precursor gene; Screening method